Synonyms: KO947
Compound class:
Synthetic organic
Comment: KO-947 is an ERK1/2 inhibitor that is in early stage clinical development as a potential treatment for advanced solid tumours with RAS/MAPK pathway mutations.
(Note: ERK1= MAPK3, ERK2= MAPK1) |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
6-benzyl-3-pyridin-4-yl-2,5-dihydro-1H-pyrazolo[4,3-g]quinazolin-7-one |
Synonyms ![]() |
KO947 |
Database Links ![]() |
|
GtoPdb PubChem SID | 374883863 |
PubChem CID | 136653617 |
Search Google for chemical match using the InChIKey | ODIUJYZERXVGEI-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | ODIUJYZERXVGEI |
UniChem Compound Search for chemical match using the InChIKey | ODIUJYZERXVGEI-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ODIUJYZERXVGEI-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
KO-947 (links to external site)
Cat. No. HY-112181 |